San Diego, CA -- (SBWIRE) -- 01/26/2015 -- An investigation on behalf of investors of Advaxis, Inc. (NASDAQ:ADXS) shares over potential securities laws violations by Advaxis, Inc. and certain of its directors and officers in connection certain financial statements was announced.

Ivestors who purchased shares of Advaxis, Inc. (NASDAQ:ADXS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Advaxis, Inc. (NASDAQ:ADXS) concerning whether a series of statements by Advaxis, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Shares of Advaxis, Inc. (NASDAQ:ADXS) grew from under $3 per share in November 2014 to as high as $13.74 per share on January 20, 2015.

Then January 21, 2015 an article was published that alleged that Advaxis, Inc. misstated the tumor response data for its ADXS-HPV drug in a recent corporate presentation, overstating its effectiveness in shrinking tumors.

Shares of Advaxis, Inc. (NASDAQ:ADXS) declined from almost $14 per share on January 20, 2015 to as low as $6.80 per share on January 22, 2015.

Those who purchased shares of Advaxis, Inc. (NASDAQ:ADXS) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com